FDZJ has transferred rights of Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection, which was independently developed by FDZJ, to a third-party 2019-03-14 16:20
FDZJ has transferred rights of Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection, which was independently developed by FDZJ, to a third-party.
沪ICP备10027510号-1